Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+ cell therapy

Fig. 2

Nomogram for scaling a good response rate to stem cell therapy for EnD-CAD. The nomogram was designed for scaling and calculating the probability of good response rate to cell therapy for patients with EnD-CAD by using individual baseline variable. The scales could help investigators to calculate the response rate and further predict who will be a “good responder” before applying cell infusion to treat EnD-CAD or refractory angina. Abbreviation: EnD-CAD = end-stage diffuse coronary artery disease; CCS = Canadian Cardiovascular Society; diast. Dysfxn = diastolic dysfunction

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512